Skip to main content
ST PHARM CO., LTD. logo

ST PHARM CO., LTD. — Investor Relations & Filings

Ticker · 237690 ISIN · KR7237690003 KO Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2026-02-05 Report Publication Anno…
Country KR South Korea
Listing KO 237690

About ST PHARM CO., LTD.

https://www.stpharm.co.kr/en

ST PHARM CO., LTD. is a global Contract Development and Manufacturing Organization (CDMO) specializing in Active Pharmaceutical Ingredients (APIs). The company provides technology-driven manufacturing services for gene therapies, with core expertise in oligonucleotides and various forms of RNA (xRNA), including messenger RNA (mRNA). In addition to nucleic acid-based medicines, ST Pharm offers custom manufacturing for small molecule APIs. The company's services operate under cGMP (current Good Manufacturing Practice) standards, providing comprehensive solutions that support the entire drug development lifecycle, from research and development to commercial-scale production for its global pharmaceutical partners.

Recent filings

Filing Released Lang Actions
결산실적공시예고
Report Publication Announcement Classification · 100% confidence The document is a short announcement titled '결산실적공시 예고' (Notice of Earnings Disclosure) from ST Pharm. It specifies the date on which the company intends to release its annual financial results (2026-02-09). Since it is a brief notification regarding the future publication of a report rather than the financial report itself, it falls under the Report Publication Announcement (RPA) category.
2026-02-05 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a short announcement (907 characters) notifying the public of an upcoming Investor Relations (IR) event (a conference call) scheduled for February 9, 2026. It provides details such as the date, time, location (online), and purpose (earnings call). According to the 'Menu vs Meal' rule, since this is an announcement of an event/report rather than the actual financial report or the transcript itself, it is classified as a Report Publication Announcement (RPA).
2026-02-05 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure from ST Pharm regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, duration, and terms. Since this is a specific regulatory announcement of a material business contract that does not fit into the other specialized categories like M&A or financial reports, it falls under the general regulatory filing category.
2026-01-23 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (DART system) used when an entity (in this case, the National Pension Service) crosses a 5% ownership threshold in a listed company (Estipharm). This falls under the 'Major Shareholding Notification' category.
2026-01-02 Korean
[기재정정]신규시설투자등
Capital/Financing Update Classification · 98% confidence The document is a formal regulatory filing titled '정정신고(보고)' (Correction Report) regarding '신규시설투자등' (New Facility Investment, etc.). It details changes to a previously disclosed capital investment plan, including updates to investment amounts, timelines, and production capacity. Since this is a specific regulatory disclosure regarding corporate capital expenditure and investment strategy, it falls under the 'Regulatory Filings' category as it does not fit into more specific categories like M&A or Share Issues.
2025-12-24 Korean
기타경영사항(자율공시) (정관 변경에 따른 배당기준일 안내)
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory filing from ST Pharm regarding a change in the dividend record date policy following an amendment to the articles of incorporation. It informs shareholders that the dividend record date will now be determined by the board rather than being fixed at the fiscal year-end. Since this is a general regulatory announcement regarding corporate policy and shareholder information that does not fit into specific categories like dividend payment announcements (which would specify an amount) or proxy solicitations, it is classified as a general regulatory filing.
2025-12-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.